Burden, A. David http://orcid.org/0000-0001-7395-9931
Choon, Siew Eng http://orcid.org/0000-0002-7796-5746
Gottlieb, Alice B. http://orcid.org/0000-0002-2927-8618
Navarini, Alexander A. http://orcid.org/0000-0001-7059-632X
Warren, Richard B. http://orcid.org/0000-0002-2918-6481
Funding for this research was provided by:
Boehringer Ingelheim
Article History
Accepted: 27 October 2021
First Online: 21 January 2022
Declarations
:
: This article has been published as part of a journal supplement wholly funded by Boehringer Ingelheim.
: Medical writing support was funded by Boehringer Ingelheim.
: A. David Burden has received consulting fees from AbbVie, Almirall, Boehringer Ingelheim, Celgene, Janssen, LEO Pharma, Lilly, Novartis, and UCB; and payment or honoraria for lectures and presentations from Almirall, Boehringer Ingelheim, Janssen, and Lilly. Siew Eng Choon has received consulting fees from AbbVie, Boehringer Ingelheim, Eli Lilly, Janssen, LEO Pharma, MSD, Novartis, Pfizer, Sanofi, and UCB. Alice B. Gottlieb has received honoraria as an advisory board member and consultant for AnaptsysBio, Avotres Therapeutics, Boehringer Ingelheim, Bristol Myers Squibb, GlaxoSmithKline, Janssen, Eli Lilly, Novartis, Pfizer, Sun Pharmaceuticals, Dermavant, and Xbiotech; and research grants from Boehringer Ingelheim, Incyte, Janssen, Novartis, UCB, Xbiotech, and Sun Pharmaceuticals. Alexander A. Navarini has been a consultant and advisor and/or received speaking fees and/or grants and/or served as an investigator in clinical trials for AbbVie, Almirall, Amgen, Biomed, Bristol Myers Squibb, Boehringer Ingelheim, Celgene, Eli Lilly, Galderma, GlaxoSmithKline, LEO Pharma, Janssen-Cilag, MSD, Novartis, Pfizer, Pierre Fabre Pharma, Regeneron, Sandoz, Sanofi, and UCB. Richard Warren received Grants from AbbVie, Almirall, Amgen, Celgene, Janssen, Lilly, LEO Pharma, Medac, Novartis, Pfizer, and UCB; and consulting fees from AbbVie, Almirall, Amgen, Arena, Astellas, Avillion, Biogen, Boehringer Ingelheim, Bristol Myers Squibb, Celgene, DiCE, GlaxoSmithKline, Janssen, Lilly, LEO Pharma, Medac, Novartis, Pfizer, Sanofi, Sun Pharmaceuticals, UCB, and UNION.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: The sponsor of the supplement and all authors identified and discussed the concept for each chapter and the supplement as a whole; further development of each review article was at the direction of the authors, who provided guidance to OPEN Health Communications on the content of the article, critically revised the work, and approved the content for publication.